Literature DB >> 12538907

Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method.

Marta Filizola1, Osvaldo Olmea, Harel Weinstein.   

Abstract

Recent studies employing differential epitope tagging, selective immunoprecipitation of receptor complexes and fluorescence or bioluminescence resonance energy transfer techniques provide direct evidence for heterodimerization between both closely and distantly related members of the G-protein coupled receptor (GPCR) family. Since heterodimerization appears to play a role in modulating agonist affinity, efficacy and/or trafficking properties, the molecular models of GPCRs required to understand receptor function must consider these oligomerization hypotheses. To advance knowledge in this field, we present here a computational approach based on correlated mutation analysis and the structural information contained in three-dimensional molecular models of the transmembrane regions of GPCRs built using the rhodopsin crystal structure as a template. The new subtractive correlated mutation method reveals likely heterodimerization interfaces amongst the different alternatives for the positioning of two tightly packed bundles of seven transmembrane domains next to each other in contact heterodimers of GPCRs. Predictions are applied to GPCRs in the class of opioid receptors. However, in the absence of a known structure of any GPCR dimer, the features of the method and predictions are also illustrated and analyzed for a dimeric complex of known structure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12538907     DOI: 10.1093/protein/15.11.881

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  30 in total

Review 1.  Advances in opioid pharmacology.

Authors:  Geoffrey K Gourlay
Journal:  Support Care Cancer       Date:  2004-12-21       Impact factor: 3.603

2.  Detection of pairwise residue proximity by covariation analysis for 3D-structure prediction of G-protein-coupled receptors.

Authors:  Wataru Nemoto; Takashi Imai; Takuya Takahashi; Takeshi Kikuchi; Norihisa Fujita
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

Review 3.  Look before leaping: combined opioids may not be the rave.

Authors:  Mellar P Davis; Susan B LeGrand; Ruth Lagman
Journal:  Support Care Cancer       Date:  2005-07-06       Impact factor: 3.603

Review 4.  Entropy and oligomerization in GPCRs.

Authors:  Rajkumar P Thummer; Matthew P Campbell; Mark K Dean; Marie J Frusher; Paul D Scott; Christopher A Reynolds
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Computational prediction of homodimerization of the A3 adenosine receptor.

Authors:  Soo-Kyung Kim; Kenneth A Jacobson
Journal:  J Mol Graph Model       Date:  2006-03-24       Impact factor: 2.518

Review 6.  Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.

Authors:  Patricia H Reggio
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

Review 7.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors.

Authors:  Harel Weinstein
Journal:  AAPS J       Date:  2006-01-06       Impact factor: 4.009

8.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

Review 9.  A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization.

Authors:  G Milligan
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

10.  Rhodopsin signaling and organization in heterozygote rhodopsin knockout mice.

Authors:  Yan Liang; Dimitrios Fotiadis; Tadao Maeda; Akiko Maeda; Anna Modzelewska; Slawomir Filipek; David A Saperstein; Andreas Engel; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.